Becker, Y. L., Boilard, É., Rollet-Labelle, E., Lood, C., Julien, A., Leclerc, J., Lévesque, T., Urowitz, M., Hanly, J., Gordon, C., Bae, S., Romero-Diaz, J., Sanchez-Guerrero, J., Clarke, A. E., Bernatsky, S., Wallace, D., Isenberg, D., Rahman, A., Merrill, J., Gladman, D., Bruce, I. N., Petri, M., Ginzler, E., Dooley, M. A., Ramsey-Goldman, R., Manzi, S., Jönsen, A., Alarcon, G., Vollenhoven, R. v., Aranow, C., Ruiz-Irastorza, G., Lim, S., Inanc, M., Kalunian, K., Jacobsen, S., Peschken, C., Kamen, D., Askanase, A., Buyon, J., & Fortin, P. R. (n.d.). 103 Exploratory segregation of patients upon their levels of anti- mitochondrial antibodies (AMAs) reveals associations between AMAs and disease manifestations. Lupus science & medicine, 9, A4–A6. http://access.bl.uk/ark:/81055/vdc_100172521764.0x00000f